Provention Bio is a disruptive biopharmaceutical company focused on advancing the development of investigational immunomodulatory therapies that may intercept and prevent autoimmune diseases. Provention Bio is the founding sponsor of JDRF’s T1Detect Screening Program that helps educate and bring awareness about the importance of screening for T1D and the potential benefits of early detection. In addition, Provention Bio helps to further JDRF’s mission by supporting JDRF’s TypeOneNation Educational Summits and serving as a member of JDRF’s Industry Advisory Panel.
Partner with JDRF
Meet your organization’s philanthropic goals by joining our battle to find a cure.